Allspring Global Investments’s Beam Therapeutics BEAM Stock Holding History

Allspring Global Investments’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$343K	Buy	+14,181	New	+$393K	﹤0.01%	1496
2023 Q3	–	Sell	-2,506	Closed	-$80K	–	2792
2023 Q2	$80K	Buy	2,506 +574	+30%	+$18.6K	﹤0.01%	2141
2023 Q1	$59.2K	Sell	1,932 -179	-8%	-$7.06K	﹤0.01%	2237
2022 Q4	$82.6K	Sell	2,111 -47	-2%	-$2.1K	﹤0.01%	2147
2022 Q3	$102K	Buy	2,158 +767	+55%	+$43.8K	﹤0.01%	2077
2022 Q2	$53K	Sell	1,391 -9,866	-88%	-$392K	﹤0.01%	2240
2022 Q1	$645K	Buy	11,257 +252	+2%	+$16.5K	﹤0.01%	2112
2021 Q4	$876K	Buy	+11,005	New	+$942K	﹤0.01%	2018

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Allspring Global Investments's BEAM Position: Q1 2026 in Review

Allspring Global Investments opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 14,181 shares worth $343K. The stake represents ﹤0.01% of the portfolio and ranks #1496 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in BEAM as recently as Q2 2023.

Allspring Global Investments first reported a position in BEAM in Q4 2021 and has held it in 8 quarters since. The position peaked at $876K in Q4 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Allspring Global Investments held 14,181 shares of Beam Therapeutics worth $343K as of Q1 2026.
Beam Therapeutics was a new Allspring Global Investments position in Q1 2026.
Beam Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1496 holding.
Allspring Global Investments first reported a position in Beam Therapeutics in Q4 2021 and has held it in 8 quarters since.
Allspring Global Investments's Beam Therapeutics position peaked at $876K in Q4 2021.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.